Mostra i principali dati dell'item
| dc.contributor.author | Ríos-Luci, Carla | |
| dc.contributor.author | Domínguez-Kelly, Raquel | |
| dc.contributor.author | León, Leticia G | |
| dc.contributor.author | Díaz Rodríguez, María Elena | |
| dc.contributor.author | Freire, Raimundo | |
| dc.contributor.author | Pandiella Alonso, Atanasio | |
| dc.contributor.author | Cikotiene, Inga | |
| dc.contributor.author | Padrón, José M | |
| dc.date.accessioned | 2025-11-24T09:33:11Z | |
| dc.date.available | 2025-11-24T09:33:11Z | |
| dc.date.issued | 2011-11-15 | |
| dc.identifier.citation | Ríos-Luci, C., Domínguez-Kelly, R., León, L. G., Díaz-Rodríguez, E., Freire, R., Pandiella, A., ... & Padrón, J. M. (2011). A modular approach to trim cellular targets in anticancer drug discovery. Bioorganic & medicinal chemistry letters, 21(22), 6641-6645. | es_ES |
| dc.identifier.issn | 0960-894X | |
| dc.identifier.uri | http://hdl.handle.net/10366/167984 | |
| dc.description.abstract | [EN]A Phenotypic Drug Discovery strategy was applied to study a set of pyrimidine analogs prepared by means of intramolecular oxidation-reduction reactions of N-substituted-N-(2,6-disubstituted-5-nitro-4-pyrimidinyl)aminoacetic acid methyl esters in basic media. The combined and rational use of specific assays allowed in short time reducing from all possible cellular targets to those involved in metaphase to anaphase transition. | es_ES |
| dc.language.iso | eng | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | Phenotypic Drug Discovery | es_ES |
| dc.subject | Antitumor agents | es_ES |
| dc.subject | Cell cycle | es_ES |
| dc.subject | Mitotic arrest | es_ES |
| dc.subject | Structure–activity relationships | es_ES |
| dc.subject.mesh | Drug Discovery | * |
| dc.subject.mesh | Pyrimidines | * |
| dc.subject.mesh | Structure-Activity Relationship | * |
| dc.subject.mesh | Cell Cycle | * |
| dc.subject.mesh | Oxidation-Reduction | * |
| dc.subject.mesh | Humans | * |
| dc.subject.mesh | Anaphase | * |
| dc.subject.mesh | Cell Line | * |
| dc.subject.mesh | Antineoplastic Agents | * |
| dc.subject.mesh | Metaphase | * |
| dc.subject.mesh | Neoplasms | * |
| dc.title | A modular approach to trim cellular targets in anticancer drug discovery | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publishversion | https://doi.org/10.1016/j.bmcl.2011.09.069 | es_ES |
| dc.subject.unesco | 2302 Bioquímica | es_ES |
| dc.subject.unesco | 2302.06 Quimioterapia | es_ES |
| dc.subject.unesco | 2407 Biología Celular | es_ES |
| dc.identifier.doi | 10.1016/j.bmcl.2011.09.069 | |
| dc.relation.projectID | RTICC RD06/0020/1046 | es_ES |
| dc.relation.projectID | D06/0020/0041 | es_ES |
| dc.relation.projectID | CTQ2008-06806-C02-01/BQU | es_ES |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | es_ES |
| dc.identifier.pmid | 21986585 | |
| dc.identifier.essn | 1464-3405 | |
| dc.journal.title | Bioorganic & medicinal chemistry letters | es_ES |
| dc.volume.number | 21 | es_ES |
| dc.issue.number | 22 | es_ES |
| dc.page.initial | 6641 | es_ES |
| dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es_ES |
| dc.subject.decs | relación estructura-actividad | * |
| dc.subject.decs | pirimidinas | * |
| dc.subject.decs | descubrimiento de fármacos | * |
| dc.subject.decs | neoplasias | * |
| dc.subject.decs | metafase | * |
| dc.subject.decs | ciclo celular | * |
| dc.subject.decs | humanos | * |
| dc.subject.decs | antineoplásicos | * |
| dc.subject.decs | oxidación-reducción | * |
| dc.subject.decs | línea celular | * |
| dc.subject.decs | anafase | * |








